The pain score (VAS), Beck Anxiety Inventory (BAI) and Beck Depression Inventory (BDI) of patients with cannabinoid endometriosis decreased significantly after use. The inflammatory factors IL-1, IL-6, IL-8, TNF-α were significantly decreased. Here, CXCL8 is linked to depressive symptom measurement.